CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ): 18 pipeline candidates · 1 upcoming catalyst · ~13 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
13.2 months
D/E 0.05 · 0% dilution
Lead: Phase 2
18 candidates
1 upcoming, next in ~4008d
N/A
A transparent, data-derived signal for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$8.3M
Cash
$5.7M
Quarterly Burn
$1.3M
Runway
13.2 mo
Revenue
$0
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (18 candidates)
| Drug | Phase |
|---|---|
| allostemspine | Phase 2 |
| AlloStemSpine® (CELZ-201 ADAPT) | Phase 1 |
| AlloStemSpine® Chronic Lower Back Pain (CELZ-201 ADAPT) | Phase 1 |
| AlloStem™ (CELZ-201-DDT) | Phase 1 |
| Alova | — |
| CaverStem® | — |
| CELZ-001 | Phase 1 |
| celz-100 | Preclinical |
| celz-201 | Phase 2 |
| CELZ-201 Administration | Phase 1/Phase 2 |
Showing 10 of 18 candidates. Sign up for full pipeline.
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
10
Total value held
$237K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 40,700 | $84K |
| geode capital management, llc | 38,290 | $79K |
| xtx topco ltd | 14,260 | $29K |
| susquehanna international group, llp | 10,469 | $22K |
| vanguard fiduciary trust co | 5,518 | $11K |
| wells fargo & company/mn | 5,000 | $10K |
| morgan stanley | 534 | $1K |
| fmr llc | 250 | $515 |
| sbi securities co., ltd. | 1 | $2 |
| ubs group ag | 1 | $2 |
Frequently asked questions
How many drug candidates are in CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s pipeline?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has 18 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s lead drug candidate?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s most advanced tracked candidate is allostemspine (Phase 2) for Chronic Lower Back Pain.
What is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s next catalyst?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: SOHONOS" — expected June 8, 2037.
What is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. has approximately 13.2 months of cash runway.
What is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s market capitalization?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s market capitalization is approximately $8.3M.
Get the full picture on CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.